Silver Crown Royalties
Investor Insight Silver prices breached $30/oz in the second half of May 2024 as investor demand drove prices to their highest in more than a decade. Strong imports and low…
Stock
1689 posts
Top 5 Canadian Uranium Stocks of 2024
After reaching a 17 year high of US$106 in early January, the spot uranium price spent most of Q2 consolidating under US$90 per pound. Uranium started the second quarter at…
Canada Nickel Closes Previously Announced US$15 Million Loan Facility with Auramet International, Inc.
Canada Nickel Company Inc. (‘ Canada Nickel ‘ or the ‘ Company ‘) (TSXV: CNC) (OTCQX: CNIKF) today announced that it has closed a secured loan facility with Auramet International,…
NextSource Materials Appoints Jaco Crouse as Chief Financial Officer
NextSource Materials Inc. (TSX:NEXT)(OTCQB:NSRCF) (‘NextSource’ or the ‘Company’) announces the appointment of Jaco Crouse as Chief Financial Officer (CFO) of the Company as part of its global growth strategy Mr.…
China’s Central Bank Suspends Gold Buying for Second Month
The People’s Bank of China (PBOC) revealed on Sunday that it did not purchase gold in June after doing the same in May. Since setting a record high of US$2,450…
Entitlement Offer Prospectus
Jindalee Lithium Limited (ASX:JLL) (Jindalee, the Company) is pleased to share its Entitlement Offer Prospectus. This Prospectus is primarily being issued for a non-renounceable pro-rata offer to Eligible Shareholders of…
Drill Results Extend Mineralisation at Lana Corina to 454m @ 0.93% CuEq
Culpeo Minerals Limited (Culpeo or the Company) (ASX:CPO, OTCQB:CPORF) is pleased to announce that additional results returned from drillhole CMLCD014 have increased the intersection of near-surface, high-grade copper mineralisation to…
Brightstar Fast-Tracks Development Timeline with Decision to Proceed to Definitive Feasibility Study
Brightstar Resources Limited (ASX: BTR) (Brightstar or the Company) is pleased to announce positive initial results from the ongoing 30,000m RC and Diamond drilling campaigns across its portfolio and workstreams…
First Patient Dosed with PD-L1 Nanobody in Phase 1 Therapeutic Non-Small Cell Lung Cancer Trial
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce the therapeutic…
Outcomes of a Strategic Review
Adisyn Ltd (ASX: AI1) (“Adisyn” or the “Company’) is pleased to announce the following outcomes of the Strategic Review process (ASX: 28 February 2024). Highlights: Strategic Review reveals four primary…